Lineage Cell Therapeutics
LCTX
#8146
Rank
A$0.26 B
Marketcap
$1.37
Share price
-3.07%
Change (1 day)
-11.77%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -A$38.76 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are A$6.18 Million. In 2023 the company made an earning of -A$38.32 Million a decrease over its 2022 earnings that were of -A$34.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$38.76 Million1.15%
2023 -A$38.32 Million9.83%
2022 -A$34.89 Million-54.24%
2021 -A$76.24 Million86.07%
2020 -A$40.98 Million-31.97%
2019 -A$60.23 Million-5.42%
2018 -A$63.68 Million1.1%
2017 -A$62.99 Million-31.06%
2016 -A$91.36 Million-10.38%
2015 -A$0.11 Billion29.69%
2014 -A$78.61 Million31.68%
2013 -A$59.7 Million
2011 -A$28.97 Million89.78%
2010 -A$15.27 Million206.06%
2009 -A$4.99 Million-0.58%
2008 -A$5.02 Million164.89%
2007 -A$1.9 Million-30.22%
2006 -A$2.72 Million
2002 -A$3.16 Million-41.04%
2001 -A$5.35 Million-32.04%
2000 -A$7.87 Million-11.85%
1999 -A$8.93 Million
1997 -A$5.74 Million12.12%
1996 -A$5.12 Million106.25%
1995 -A$2.48 Million-11.11%
1994 -A$2.79 Million50%
1993 -A$1.86 Million20%
1992 -A$1.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.2 Billion 388.83%๐Ÿ‡บ๐Ÿ‡ธ USA